17th Annual Psychopharmacology Update | CME Program Schedule

Psychopharmacology Update | 24 CME/CE

Women's Psychiatric Health & Disorders Pre-conference | Schizophrenia & Psychosis Post-conference

	Thursday, February 16	Friday, February 17	Saturday, February 18
7:00- 8:00am	Full breakfast with exhibitors
8:00- 9:00am	Anxiety 1: Managing Social Phobia: Learning to be Confident Michael R. Liebowitz, MD Professor of Clinical Psychiatry Columbia University Read bio	Mood 1: Pharmacological Management of Dysthymia Hagop S. Akiskal, MD Director of International Mood Center, Editor-in-Chief, Journal of Affective Disorders, University of California at San Diego Read bio	Dementia: Mild Treatments to Slow Disease Progression During the Mild-Moderate Stage Jeffrey L. Cummings, MD Director, Cleveland Clinic Lou Ruvo Center for Brain Health Read bio
9:00- 10:00am	Anxiety 2: Panic Disorders Mark H. Pollack, MD Professor and Chairman of Psychiatry, Rush University Medical Center Read bio	Mood 2: Treatment of Major Depressive Disorder Guided by Quantitative-EEG (QEEG) Daniel A. Hoffman, MD Medical Director, Neuro-Therapy Clinic; Chief Medical Officer, CNS Response Read bio	Dementia 2: Moderate-Severe Addressing Behavioral Manifestations (Understanding the Black Box Warning for the Use of Antipsychotic Agents) Rajesh R. Tampi, MD, MS, FAPA Associate Clinical Professor of Psychiatry, Yale University Read bio
10:00- 10:15am	Networking break with exhibitors
10:15- 11:15am	Anxiety 3: Generalized Anxiety Disorder Michael Liebowitz, MD Professor of Psychiatry Columbia University Read bio	Mood 3: Results of LiTMUS Trial for Management of Bipolar Disorder Michael E. Thase, MD Professor of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia Veterans Affairs Medical Center Read bio	Child 1: Psychopharmacology of Autism Christopher John McDougle, MD Director, Lurie Autism Center; Professor of Psychiatry and Pediatrics, Massachusetts General Hospital and MassGeneral Hospital for Children, Nancy Lurie Marks Professor, Harvard Medical School Read bio
11:15- 12:15pm	Anxiety 4: Algorithm for the Pharmacology of PTSD David N. Osser, MD Professor of Psychiatry, Harvard Medical School Read bio	Mood 4: Treatment of Refractory and Rapid Cycling Bipolar Disorder Nathan N. Mason, MD Assistant Professor, University of Nevada Read bio	Child 2: Guanfacine with CNS Stimulants (Rational Polypharmacy for ADHD) Sharon Wigal, MD Associate Clinical Professor, Director of Clinical Trails, Child Development Center, Pediatrics, University of California at Irvine Read bio
12:15- 1:30pm	Lunch	Lunch Product Theater: Challenges & Opportunities in Schizophrenia Leslie Citrome, MD, MPH Presented by Sunovion Pharmaceuticals	Lunch
1:30- 2:30pm	Somatoform 1: Body Dysmorphic Disorder Katherine Phillips, MD Professor of Psychiatry and Human Behavior, Brown University Read bio	Substance Abuse 1: Treating Comorbid Chronic Pain and Opioid Addiction Sean Mackey, MD, PhD Associate Professor, Anesthesia & Pain Management, Stanford University Read bio	Child 3: Use of Antipsychotics for Children John W. Goethe, MD Director, Burlingame Center for Psychiatric Research and Education, Institute of Living, Hartford, Connecticut Read bio
2:30- 3:30pm	Somatoform 2: Recognizing and Treating Seizures Alan G. Stein, MD Medical Director, Epilepsy and Neurophysiology, The Queen's Medical Center; Assistant Clinical Professor of Neurology, Department of Medicine, University of Hawaii Read bio	Substance Abuse 2: Neurobiology of Opioid Dependence and its Treatment Paul H. Earley, MD Medical Director, Talbott Recovery Campus, Atlanta Georgia Read bio	Ethics 1*: Children's Issues Charles Scott, MD Chief, Division of Psychiatry and the Law/Professor of Clinical Psychiatry, University of California, Davis Medical Center - Sacremento Read bio
3:30- 3:45pm	Networking break with exhibitors
3:45- 4:45pm	Borderline Personality Disorder: New Findings and Treatment Recommendations John M. Oldham, MD, MS Senior Vice President & Chief of Staff, The Menninger Clinic; Professor and Executive Vice Chair, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine; President, American Psychiatric Association Read bio	Substance Abuse 3: Potential Approaches to Pharmacologic Treatment of Methamphetamine Dependence Andrew Saxon, MD Professor, University of Washington Department of Psychiatry and Behavioral Sciences Read bio	Ethics 2*: An Overview of "The Principles of Medical Ethics" Wayne Levy, MD Clinical Director of Outpatient Psychiatry, Tripler Army Medical Center Read bio
4:45- 5:45pm	Case Presentation: Anxious Woman with Borderline Personality Disorder and Fibromyalgia Moderated Discussion with Thursday's Faculty Members	Case Presentation: Bipolar man with migraine headaches and ADHD, requesting mood stabilizers, opioids, and amphetamines Moderated Discussion with Friday's Faculty Members	Case Presentation: Twitching child living in an abuse/dysfunctional home and an older man with cognitive impairment who won't stop driving Moderated Discussion with Saturday's Faculty Members

* Counts as continuing education ethics course

Welcome Reception in Exhibit Hall | Thursday, 6:00 - 7:00 pm
Please join us for complimentary appetizers and beverages in the Exhibit Hall to kick off the 17th Annual Psychopharmacology Conference!

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Nevada School of Medicine and Nevada Psychiatric Association. The University of Nevada School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.

Designation

Physicians: The University of Nevada School of Medicine designates this live activity for a maximum of 39 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing: The University of Nevada School of Medicine is a provider of continuing education credit activities for nurses. This program is approved for 39.00 hours of nursing continuing education credit. Nurses residing outside the state of Nevada who participate in a University of Nevada School of Medicine sponsored activity should check with his/her licensure board to determine acceptability of Nevada nursing credits.

The American Nurses Credentialing Center (ANCC) recognizes and accepts Accreditation Council for Continuing Education (ACCME) credits to satisfy professional development continuing education hour requirements for nursing. Learn more about ANCC Certification Renewal Requirements

Breakdown of CME/CE Credits by Day:

Women's Psychiatric Health & Disorders Pre-conference: 8
Psychopharmacology Update: 24
Schizophrenia & Psychosis Post-conference: 7

Disclosure

It is the policy of NPA and UNSOM to comply with the ACCME standards for commercial support of CME. Planning Committee members and related staff disclosures must be on file annually with disclosures made available on program materials. Faculty participating in jointly sponsored programs by UNSOM are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation. Faculty also are responsible for disclosing any discussion of off-label or investigational use of a product.

In accordance with the ACCME requirements on disclosure, information about relationships of presenters with commercial interests, if any, will be included in materials distributed at the time of the conference.

General Course Information

The NPA 17th Annual Psychopharmacology Conference is a nonsmoking event. Infants and children are not allowed in the meeting room or exhibit hall. Cell phones, pagers, and PDAs must be turned off during educational sessions. Please be courteous to your fellow attendees. Dress is business casual. Nevada Psychiatric Association reserves the right to substitute faculty or to cancel or reschedule sessions due to unforeseen circumstances.